The Home of the Life Sciences Industry

Courtesy of John Tlumacki/The Boston Globe via Get

Report: Second Patient Death Potentially Linked to Eisai and Biogen’s Lecanemab

A second patient death has been linked to the Phase III clinical trial of Eisai and Biogen’s investigational Alzheimer's drug lecanemab, according to the journal Science.
Taljat David/Shutterstock

FDA Accepts BLA for Roche & Sarepta's DMD Gene Therapy

The FDA has accepted Roche and Sarepta's BLA for the accelerated approval of SRP-9001, an investigational gene therapy for DMD.
Courtesy of Sarah Silbiger/Getty Images

Spectrum Cuts NSCLC Program and 75% of Staff on Heels of CRL

Courtesy of Getty Images

Axsome Headed to FDA after Phase III Alzheimer's Agitation Win

Leon Neal/Getty Images

AstraZeneca and C4X Discovery Ink $402M COPD Collaboration

Search Life Sciences Jobs:

More Top Stories

View more news

Now Hiring

View all Featured Employers

Careers

Courtesy Phunkod/Getty Images

How to Enhance Your Personal Executive Brand and Expand Your Influence

Dr. Kiana Aran, Courtesy of the Keck Graduate Inst

Breaking the Silos: How One Doctor is Working to Reshape Medicine

What You Need to Know Before Applying to a Small Pharma Company

In case you missed it

Courtesy of John Tlumacki/The Boston Globe via Get

11/28/2022

Report: Second Patient Death Potentially Linked to Eisai and Biogen’s Lecanemab

Taljat David/Shutterstock

11/28/2022

FDA Accepts BLA for Roche & Sarepta's DMD Gene Therapy

Courtesy of Sarah Silbiger/Getty Images

11/28/2022

Spectrum Cuts NSCLC Program and 75% of Staff on Heels of CRL

Courtesy of Getty Images

11/28/2022

Axsome Headed to FDA after Phase III Alzheimer's Agitation Win

Leon Neal/Getty Images

11/28/2022

AstraZeneca and C4X Discovery Ink $402M COPD Collaboration

Hotbeds

View all Hotbeds

Clinical Research

Courtesy of John Tlumacki/The Boston Globe via Get

11/28/2022

Report: Second Patient Death Potentially Linked to Eisai and Biogen’s Lecanemab

Courtesy of Getty Images

11/28/2022

Axsome Headed to FDA after Phase III Alzheimer's Agitation Win

Courtesy Shutterstock

11/28/2022

CinCor Touts Subgroup Analysis in Mid-stage Hypertension Study as Shares Crash

Courtesy of Getty Images

11/24/2022

Gratitude and Optimism: This Thanksgiving, BioSpace Celebrates Biopharma Wins 

Finance

Courtesy of Sarah Silbiger/Getty Images

Spectrum Cuts NSCLC Program and 75% of Staff on Heels of CRL

PepGen CFO Noel Donnelly/courtesy of PepGen

Recession Survival Strategies for Newly Public Biopharma Companies

Covid-19

Courtesy of Getty Images

Gratitude and Optimism: This Thanksgiving, BioSpace Celebrates Biopharma Wins 

Getty Images

Pfizer-BioNTech, Moderna Tout New Data for Updated Omicron Boosters

Women in Life Sciences

The Black Employee Experience

The Black Employee Experience

US Life Sciences Salary Report

Best Places to Work in Biopharma